Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioRegenx, Inc. BRGX

Full chart Compare
Set alert

Price alert · BRGX

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.004 Day range 0.004
0.0002 52-week range 0.024
YTD
-98.45%
1 year
-98.00%

Financial health

Altman Z-Score

-166.57 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -8.1×
FY 2015: 273×FY 2017: -106×FY 2018: 0.0×FY 2019: -19.3×FY 2020: -126×FY 2021: -51.3×FY 2022: -183×FY 2023: -11.2×FY 2024: -0.4×FY 2025: -8.1×
FY 2015 5y median -11.2× FY 2025
P/S 6.7×
FY 2015: 7.5×FY 2017: 63.3×FY 2018: 0.0×FY 2019: 8.6×FY 2020: 100×FY 2021: 27.8×FY 2022: 352×FY 2023: 292×FY 2024: 3.6×FY 2025: 6.7×
FY 2015 5y median 27.8× FY 2025
P/B -2.7×
FY 2015: 89.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 287×FY 2020: 228×FY 2021: -65.6×FY 2022: -73.6×FY 2023: -29.3×FY 2024: -2.5×FY 2025: -2.7×
FY 2015 5y median -29.3× FY 2025
P/FCF 414×
FY 2015: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -28.8×FY 2020: -430×FY 2021: -36.6×FY 2022: -229×FY 2023: -487×FY 2024: -16.5×FY 2025: 414×
FY 2015 5y median -36.6× FY 2025
EV/EBITDA -32.7×
FY 2015: 214×FY 2017: 0.0×FY 2018: 0.1×FY 2019: -19.9×FY 2020: -267×FY 2021: -35.4×FY 2022: -208×FY 2023: -11.8×FY 2024: -0.5×FY 2025: -32.7×
FY 2015 5y median -32.7× FY 2025
EV/Sales 7.8×
FY 2015: 7.5×FY 2017: 0.0×FY 2018: -0.0×FY 2019: 8.5×FY 2020: 100×FY 2021: 28.7×FY 2022: 358×FY 2023: 296×FY 2024: 4.5×FY 2025: 7.8×
FY 2015 5y median 28.7× FY 2025
FCF Yield 0.2%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -3.5%FY 2020: -0.2%FY 2021: -2.7%FY 2022: -0.4%FY 2023: -0.2%FY 2024: -6.1%FY 2025: 0.2%
FY 2015 5y median -0.4% FY 2025

Profitability

Gross Margin 81.1%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 99.5%FY 2019: 55.4%FY 2020: 88.9%FY 2021: 99.7%FY 2022: 85.9%FY 2023: 73.3%FY 2024: 70.9%FY 2025: 81.1%
FY 2015 5y median 81.1% FY 2025
Operating Margin -28.0%
FY 2015: 3.5%FY 2017: -27.6%FY 2018: -18.3%FY 2019: -43.9%FY 2020: -53.4%FY 2021: -83.1%FY 2022: -185.7%FY 2023: -494.5%FY 2024: -972.8%FY 2025: -28.0%
FY 2015 5y median -185.7% FY 2025
Net Margin -83.2%
FY 2015: 2.7%FY 2017: -30.3%FY 2018: -18.3%FY 2019: -43.5%FY 2020: -82.1%FY 2021: -48.8%FY 2022: -185.7%FY 2023: -2567.1%FY 2024: -985.2%FY 2025: -83.2%
FY 2015 5y median -185.7% FY 2025
ROE 34.0%
FY 2015: 32.7%FY 2017: 0.0%FY 2018: -104.1%FY 2019: -1460.4%FY 2020: -186.9%FY 2021: 115.0%FY 2022: 38.9%FY 2023: 257.2%FY 2024: 682.2%FY 2025: 34.0%
FY 2015 5y median 115.0% FY 2025
ROIC 32.0%
FY 2015: 41.6%FY 2017: 0.0%FY 2018: 338.9%FY 2019: -2712.5%FY 2020: -65.9%FY 2021: -142.5%FY 2022: -198.6%FY 2023: -16.8%FY 2024: 1873.5%FY 2025: 32.0%
FY 2015 5y median -16.8% FY 2025
ROA -375.6%
FY 2015: 9.2%FY 2017: 0.0%FY 2018: -76.8%FY 2019: -226.7%FY 2020: -90.3%FY 2021: -75.8%FY 2022: -132.4%FY 2023: -1804.7%FY 2024: -4533.4%FY 2025: -375.6%
FY 2015 5y median -375.6% FY 2025

Growth (YoY)

Revenue -20.7%
FY 2015: 79.5%FY 2017: 0.0%FY 2018: -4.0%FY 2019: 85.4%FY 2020: -15.4%FY 2021: -50.9%FY 2022: -78.8%FY 2023: -47.2%FY 2024: 10420.2%FY 2025: -20.7%
FY 2015 FY 2025
Operating Income 97.7%
FY 2015: 134.5%FY 2017: 0.0%FY 2018: 36.1%FY 2019: -343.7%FY 2020: -2.9%FY 2021: 23.6%FY 2022: 52.5%FY 2023: -40.5%FY 2024: -20594.0%FY 2025: 97.7%
FY 2015 FY 2025
EPS (diluted) 92.0%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: -50.0%FY 2021: 66.7%FY 2022: 25.0%FY 2023: -600.0%FY 2024: -852.4%FY 2025: 92.0%
FY 2015 FY 2025
Free Cash Flow 105.8%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -151.0%FY 2020: 33.9%FY 2021: -60.5%FY 2022: 57.2%FY 2023: 79.4%FY 2024: -3747.6%FY 2025: 105.8%
FY 2015 FY 2025

Financial Health

Current Ratio 0.1×
FY 2015: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: 2.3×FY 2021: 1.7×FY 2022: 0.0×FY 2023: 2.6×FY 2024: 0.1×FY 2025: 0.1×
FY 2015 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2015: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: -18.2×FY 2021: -44.4×FY 2022: 0.0×FY 2023: 2.6×FY 2024: 0.1×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
Debt / Equity -0.5×
FY 2015: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.8×FY 2021: -2.4×FY 2022: -1.2×FY 2023: -1.0×FY 2024: -0.6×FY 2025: -0.5×
FY 2015 5y median -1.0× FY 2025
Net Debt / EBITDA -4.8×
FY 2015: -0.5×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.2×FY 2020: -0.4×FY 2021: -1.1×FY 2022: -3.3×FY 2023: -0.2×FY 2024: -0.1×FY 2025: -4.8×
FY 2015 5y median -1.1× FY 2025
Interest Coverage 1.7×
FY 2015: 4.7×FY 2017: -10.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -13.3×FY 2024: -78.3×FY 2025: 1.7×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31